(–)-trans-Cannabidiol, PhG isolate

Active Pharmaceutical IngredientPh.Eur. 3151
Subsatnce Origin: Cannabis Sativa L.
Certifications: Czech Medicines Agency (SUKL.cz), ISO 9001:2015, ISO 14001:2015

Pharma Grade, Active substance for pharmaceutical use.
Substance origin: chemical synthesis
Conforms with quality criteria: DAC/NRF 2016/2, C-052

CBDepot group starts the marketing of synthesized pharma-grade CBD produced under the EU GMP umbrella of its sister company CB21 Pharma, s.r.o.

CB21 Pharma, a leading Czech-based pharmaceutical company specializing in producing cannabinoid ingredients and medical devices, has successfully extended its EU Good Manufacturing Practice (GMP) certification under certificate # sukls105303/2023. This achievement allows CB21 Pharma, the spin-off sister company to pioneering CBDepot, to continue manufacturing Active Pharmaceutical Ingredients (APIs) such as Cannabidiol (CBD), from initial extraction to the production of full spectrum distilled and standardized extracts from medicinal cannabis, marketed as Cannabis Extractum Raffinatum and Cannabis Extractum Normatum.